Bay 11‐7082, an NF ‐ κB Inhibitor, Prevents Post‐Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.13207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Juwon Moon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Melanins, Hyperpigmentation, NF-kappa B, Nitriles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Post‐inflammatory hyperpigmentation (PIH) is a very common disorder of cutaneous hyperpigmentation, which poses a persistent management challenge in the fields of dermatology and esthetics. This study was designed to explore the anti‐melanogenic and anti‐inflammatory effects of Bay 11‐7082, an NF‐κB inhibitor, using small‐molecule screening, to determine its potential application for PIH prevention. The molecular mechanisms were investigated in vitro and ex vivo in epidermis‐humanized mice using melanin content, RT‐PCR, and immunoblotting. Bay 11‐7082 suppressed proinflammatory cytokines and ameliorated 2,4‐dinitrofluorobenzene (DNFB)‐induced contact dermatitis on day 15. The suppression of melanin synthesis by Bay 11‐7082 was attributed to the reduction of MITF, which was induced by extracellular signal‐regulated kinase activation. Bay 11‐7082 reduced epidermal melanin accumulation in UVB‐stimulated ex vivo human epidermis as well as in the ear and tail skin of K14‐stem cell factor (SCF) transgenic mice. Topical administration of Bay 11‐7082 improved PIH on day 35 in the post‐DNFB dorsal skin of K14‐SCF transgenic mice. In conclusion, Bay 11‐7082 can be considered a promising candidate for the development of a preventive topical agent for PIH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Brain Science, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
ORCID-Profile: Ik Jun Moon, Youngsup Song
Förderung
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Moon, J., Moon, I. J., Hyun, H., Yoo, J. M., Bang, S. H., Song, Y., & Chang, S. E. (2025). Bay 11‐7082, an NF ‐ κB Inhibitor, Prevents Post‐Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13207
Vancouver
Moon J, Moon IJ, Hyun H, Yoo JM, Bang SH, Song Y, et al. Bay 11‐7082, an NF ‐ κB Inhibitor, Prevents Post‐Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.13207
BibTeX
@article{Moon2025,
author = {Moon, Juwon and Moon, Ik Jun and Hyun, Hoyong and Yoo, Jae Min and Bang, Seung Hyun and Song, Youngsup and Chang, Sung Eun},
title = {Bay 11‐7082, an NF ‐ κB Inhibitor, Prevents Post‐Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.13207}
}
EUVIMED